Compounds > nad
Page last updated: 2024-08-17

nad and angiotensin ii

nad has been researched along with angiotensin ii in 31 studies

Research

Studies (31)

TimeframeStudies, this research(%)All Research%
pre-19905 (16.13)18.7374
1990's5 (16.13)18.2507
2000's12 (38.71)29.6817
2010's5 (16.13)24.3611
2020's4 (12.90)2.80

Authors

AuthorsStudies
Nakamura, S; Rodbell, M1
Freissmuth, M; Nanoff, C; Schütz, W; Tuisl, E1
Fluharty, SJ; Monck, JR; Rogulja, I; Williamson, JR; Williamson, RE1
Hansford, RG1
DeCandido, S; Satriano, JA; Schlondorff, D1
Haynes, RC; Sistare, FD2
Oelkers, W; von Goldacker, IU1
Egorova, A; Higashida, H; Hoshi, N; Noda, M1
Dobos, A; Rohács, T; Spät, A; Tory, K1
Donaldson, F; Lang, D; Lewis, MJ; Mosfer, SI; Shakesby, A1
Grant, S; Griendling, KK; Harrison, DG; Lassègue, B; Somers, MJ; Sorescu, D1
August, M; Bodenschatz, M; Förstermann, U; Griendling, K; Kleschyov, AL; Lassègue, B; Li, H; Meinertz, T; Mollnau, H; Münzel, T; Oelze, M; Schulz, E; Szöcs, K; Tsilimingas, N; Walter, U; Wendt, M1
Danser, AH; de Vries, R; Saxena, PR; Schuijt, MP; Sluiter, W; Tom, B; van Kats, JP1
Pitter, JG; Spät, A1
Barron, JT; Nair, A; Sasse, MF1
Manea, A; Raicu, M; Simionescu, M1
Gupta, M; Gupta, MP; Lang, R; Pillai, JB; Rajamohan, SB; Raman, J1
Kahn, AM; Yang, M1
Au, AL; Chan, MS; Chan, SW; Kwan, YW; Seto, SW1
Birukov, KG; Gupta, M; Gupta, MP; Hottiger, MO; Pillai, VB; Rajamohan, SB; Samant, S; Sundaresan, NR1
Akar, F; Sepici, A; Soylemez, S1
Cai, Y; Chen, SR; Ji, Y; Liu, PQ; Pi, RB; Shen, XY; Ye, JT; Yu, SS1
Cai, Y; Chen, SR; Gao, S; Li, H; Liu, PQ; Pi, RB; Ye, JT; Yu, SS1
Chen, S; Chen, X; Fang, W; Gao, H; Gao, S; Geng, B; Li, H; Li, Z; Liu, M; Liu, P; Ma, Y; Ye, J; Yue, Z; Zhang, L; Zou, J1
Chen, GW; Li, Z; Li, ZM; Liu, M; Liu, PQ; Luo, HB; Wang, LP; Ye, JT1
Fu, H; Huang, F; Li, DJ; Ni, M; Shen, FM; Zhang, LS1
Agarwal, G; Ahmadieh, S; Benjamin, S; Benson, TW; Blomkalns, AL; Edgell, A; Fulton, DJ; Gilreath, N; Horimatsu, T; Huo, Y; Kim, D; Kim, HW; Mann, A; Moses, M; Offermanns, S; Ogbi, M; Patel, S; Pye, J; Reid, L; Robbins, N; Singh, N; Stansfield, BK; Thompson, A; Weintraub, NL1
Chen, Z; Ding, G; Feng, J; Hao, Y; Hu, J; Liang, W; Luo, Q; Luo, Z; Yang, X; Zhang, Z; Zhu, Z1
Abudupataer, M; Lai, H; Li, J; Ming, Y; Wang, C; Xiang, B; Yin, X; Zhu, K1
Cao, K; Chen, P; Cui, Y; Dai, X; Feng, D; Fu, X; Guo, S; He, J; Li, Z; Song, M; Wang, C; Wang, L; Xu, Y1

Reviews

1 review(s) available for nad and angiotensin ii

ArticleYear
Relation between mitochondrial calcium transport and control of energy metabolism.
    Reviews of physiology, biochemistry and pharmacology, 1985, Volume: 102

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Adrenergic alpha-Agonists; Angiotensin II; Animals; Biological Transport; Calcium; Cytosol; Energy Metabolism; Enzyme Activation; Glycerolphosphate Dehydrogenase; Isocitrate Dehydrogenase; Ketoglutarate Dehydrogenase Complex; Kidney; Kinetics; Mitochondria; Mitochondria, Heart; Mitochondria, Liver; Models, Biological; Muscles; Myocardium; NAD; Nerve Tissue; Oxidoreductases; Phenylephrine; Pyruvate Dehydrogenase (Lipoamide)-Phosphatase; Vasopressins

1985

Other Studies

30 other study(ies) available for nad and angiotensin ii

ArticleYear
Glucagon induces disaggregation of polymer-like structures of the alpha subunit of the stimulatory G protein in liver membranes.
    Proceedings of the National Academy of Sciences of the United States of America, 1991, Aug-15, Volume: 88, Issue:16

    Topics: Angiotensin II; Animals; Cell Membrane; Centrifugation, Density Gradient; Cholera Toxin; Glucagon; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Kinetics; Liver; Macromolecular Substances; NAD; Rats; Vasopressins

1991
P2-, but not P1-purinoceptors mediate formation of 1, 4, 5-inositol trisphosphate and its metabolites via a pertussis toxin-insensitive pathway in the rat renal cortex.
    British journal of pharmacology, 1990, Volume: 100, Issue:1

    Topics: Adenine Nucleotides; Angiotensin II; Animals; Enzyme Activation; GTP-Binding Proteins; In Vitro Techniques; Inosine Nucleotides; Inosine Triphosphate; Kidney Cortex; Male; NAD; Norepinephrine; Pertussis Toxin; Rats; Rats, Inbred Strains; Receptors, Purinergic; Type C Phospholipases; Virulence Factors, Bordetella

1990
Angiotensin II effects on the cytosolic free Ca2+ concentration in N1E-115 neuroblastoma cells: kinetic properties of the Ca2+ transient measured in single fura-2-loaded cells.
    Journal of neurochemistry, 1990, Volume: 54, Issue:1

    Topics: Angiotensin II; Animals; Benzofurans; Bradykinin; Calcium; Cell Differentiation; Cell Division; Cell Line; Cytosol; Fluorescent Dyes; Fura-2; Inositol Phosphates; Kinetics; Mice; NAD; Neuroblastoma; Pertussis Toxin; Tumor Cells, Cultured; Virulence Factors, Bordetella

1990
Different concentrations of pertussis toxin have opposite effects on agonist-induced PGE2 formation in mesangial cells.
    Biochemical and biophysical research communications, 1986, Nov-26, Volume: 141, Issue:1

    Topics: Angiotensin II; Animals; Calcimycin; Cells, Cultured; Dinoprostone; Dose-Response Relationship, Drug; GTP-Binding Proteins; In Vitro Techniques; Kidney Glomerulus; Membrane Proteins; Molecular Weight; NAD; Pertussis Toxin; Platelet Activating Factor; Prostaglandins E; Rats; Virulence Factors, Bordetella

1986
The interaction between the cytosolic pyridine nucleotide redox potential and gluconeogenesis from lactate/pyruvate in isolated rat hepatocytes. Implications for investigations of hormone action.
    The Journal of biological chemistry, 1985, Oct-15, Volume: 260, Issue:23

    Topics: Angiotensin II; Animals; Cytosol; Dexamethasone; Glucagon; Gluconeogenesis; Glyceraldehyde-3-Phosphate Dehydrogenases; Kinetics; Lactates; Lactic Acid; Liver; Malate Dehydrogenase; Male; NAD; Oxaloacetates; Oxidation-Reduction; Pyruvate Kinase; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains

1985
Estimation of the relative contributions of enhanced production of oxalacetate and inhibition of pyruvate kinase to acute hormonal stimulation of gluconeogenesis in rat hepatocytes. An analysis of the effects of glucagon, angiotensin II, and dexamethasone
    The Journal of biological chemistry, 1985, Oct-15, Volume: 260, Issue:23

    Topics: Adenosine Diphosphate; Adenosine Triphosphate; Angiotensin II; Animals; Cytosol; Dexamethasone; Glucagon; Glucocorticoids; Gluconeogenesis; Glyceric Acids; Hormones; Kinetics; Lactates; Lactic Acid; Liver; Male; NAD; Oxaloacetates; Pyruvate Kinase; Pyruvates; Pyruvic Acid; Rats; Rats, Inbred Strains

1985
[Determination of the angiotensinase-(aminopeptidase-)activity in blood using a DPN. H-dependent optical test].
    Klinische Wochenschrift, 1967, Jun-15, Volume: 45, Issue:12

    Topics: Aminopeptidases; Angiotensin II; Clinical Enzyme Tests; Endopeptidases; Enzymes; Humans; Hydrogen-Ion Concentration; NAD

1967
Streptozotocin, an inducer of NAD+ decrease, attenuates M-potassium current inhibition by ATP, bradykinin, angiotensin II, endothelin 1 and acetylcholine in NG108-15 cells.
    FEBS letters, 1996, Feb-05, Volume: 379, Issue:3

    Topics: Acetylcholine; Adenosine Triphosphate; Angiotensin II; Animals; Bradykinin; Endothelins; Glioma; Hybrid Cells; Mice; NAD; Neuroblastoma; Neurons; Potassium; Rats; Signal Transduction; Streptozocin; Tumor Cells, Cultured

1996
Intracellular calcium release is more efficient than calcium influx in stimulating mitochondrial NAD(P)H formation in adrenal glomerulosa cells.
    The Biochemical journal, 1997, Dec-01, Volume: 328 ( Pt 2)

    Topics: Angiotensin II; Animals; Calcium; Cations, Divalent; Cations, Monovalent; Ion Transport; Male; Mitochondria; NAD; NADP; Oxidation-Reduction; Potassium; Rats; Rats, Wistar; Signal Transduction; Vasopressins; Zona Glomerulosa

1997
Coronary microvascular endothelial cell redox state in left ventricular hypertrophy : the role of angiotensin II.
    Circulation research, 2000, Mar-03, Volume: 86, Issue:4

    Topics: Angiotensin II; Animals; Cells, Cultured; Coronary Circulation; Cytochrome c Group; Endothelium, Vascular; Guinea Pigs; Heart Ventricles; Hypertrophy, Left Ventricular; Microcirculation; Myocardium; NAD; NADPH Oxidases; Organ Size; Oxidation-Reduction; Superoxides

2000
Electron spin resonance characterization of the NAD(P)H oxidase in vascular smooth muscle cells.
    Free radical biology & medicine, 2001, Mar-15, Volume: 30, Issue:6

    Topics: Acridines; Angiotensin II; Animals; Cell Membrane; Cells, Cultured; Cyclic N-Oxides; Electron Spin Resonance Spectroscopy; Male; Muscle, Smooth, Vascular; NAD; NADP; NADPH Oxidases; Platelet-Derived Growth Factor; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Spin Labels; Substrate Specificity; Superoxides

2001
Effects of angiotensin II infusion on the expression and function of NAD(P)H oxidase and components of nitric oxide/cGMP signaling.
    Circulation research, 2002, Mar-08, Volume: 90, Issue:4

    Topics: Angiotensin II; Animals; Aorta; Blood Pressure; Cell Adhesion Molecules; Cyclic GMP; Cyclic GMP-Dependent Protein Kinase Type I; Cyclic GMP-Dependent Protein Kinases; Disease Models, Animal; Enzyme Activation; Guanylate Cyclase; In Vitro Techniques; Infusions, Parenteral; Membrane Glycoproteins; Membrane Transport Proteins; Microfilament Proteins; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Dehydrogenase; NADPH Oxidase 1; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Phosphoproteins; Protein Kinase C; Rats; Rats, Wistar; Receptors, Cytoplasmic and Nuclear; Signal Transduction; Soluble Guanylyl Cyclase; Superoxides; Vasodilation; Vasodilator Agents

2002
Superoxide does not mediate the acute vasoconstrictor effects of angiotensin II: a study in human and porcine arteries.
    Journal of hypertension, 2003, Volume: 21, Issue:12

    Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetophenones; Adolescent; Adult; Angiotensin II; Animals; Catecholamines; Child; Child, Preschool; Coronary Vessels; Cyclic N-Oxides; Dopamine Agonists; Dose-Response Relationship, Drug; Endothelin-1; Enzyme Inhibitors; Female; Femoral Artery; Free Radical Scavengers; Humans; Imidazolines; Male; Myocardial Contraction; NAD; NADP; Nitroprusside; Oxidants; S-Nitroso-N-Acetylpenicillamine; Spin Labels; Superoxide Dismutase; Superoxides; Swine; Time Factors; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Vasodilator Agents; Xanthine Oxidase

2003
The effect of cytoplasmic Ca2+ signal on the redox state of mitochondrial pyridine nucleotides.
    Molecular and cellular endocrinology, 2004, Feb-27, Volume: 215, Issue:1-2

    Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; Cytoplasm; Mitochondria; NAD; NADP; Oxidation-Reduction; Potassium; Rats; Vasoconstrictor Agents; Vasopressins; Zona Glomerulosa

2004
Effect of angiotensin II on energetics, glucose metabolism and cytosolic NADH/NAD and NADPH/NADP redox in vascular smooth muscle.
    Molecular and cellular biochemistry, 2004, Volume: 262, Issue:1-2

    Topics: Angiotensin II; Animals; Carotid Arteries; Cytosol; Energy Metabolism; Glucose; Kinetics; NAD; NADP; NADPH Oxidases; Oxidation-Reduction; Swine; Vasoconstriction

2004
Expression of functionally phagocyte-type NAD(P)H oxidase in pericytes: effect of angiotensin II and high glucose.
    Biology of the cell, 2005, Volume: 97, Issue:9

    Topics: Angiotensin II; Animals; Calcium; Cell Proliferation; Glucose; Humans; Molecular Sequence Data; NAD; NADH, NADPH Oxidoreductases; NADP; NADPH Oxidases; Pericytes; Phagocytes; Protein Subunits; Rats; Rats, Wistar; Reactive Oxygen Species; RNA, Messenger; Superoxides

2005
Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy.
    American journal of physiology. Heart and circulatory physiology, 2006, Volume: 291, Issue:4

    Topics: Angiotensin II; Animals; Cardiomegaly; Cells, Cultured; Endomyocardial Fibrosis; Gene Expression Regulation, Enzymologic; Mice; Mice, Knockout; Muscle Cells; Myocardium; NAD; Oxidative Stress; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Signal Transduction; Sirtuin 1; Sirtuins

2006
Insulin-stimulated NADH/NAD+ redox state increases NAD(P)H oxidase activity in cultured rat vascular smooth muscle cells.
    American journal of hypertension, 2006, Volume: 19, Issue:6

    Topics: Angiotensin II; Animals; Aorta, Thoracic; Cell Movement; Cells, Cultured; Drug Synergism; Enzyme Activation; Hypoglycemic Agents; Insulin; Lactic Acid; Male; Muscle, Smooth, Vascular; NAD; NADPH Oxidases; Oxidation-Reduction; Pyruvic Acid; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents

2006
Modulation by homocysteine of the iberiotoxin-sensitive, Ca2+ -activated K+ channels of porcine coronary artery smooth muscle cells.
    European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3

    Topics: 1,2-Dihydroxybenzene-3,5-Disulfonic Acid Disodium Salt; Acetophenones; Angiotensin II; Animals; Benzimidazoles; Calcium; Coronary Vessels; Dose-Response Relationship, Drug; Enzyme Activation; Enzyme Inhibitors; Homocysteine; In Vitro Techniques; Ion Channel Gating; Membrane Potentials; Muscle, Smooth, Vascular; NAD; NADPH Oxidases; Patch-Clamp Techniques; Peptides; Potassium Channel Blockers; Potassium Channels, Calcium-Activated; Superoxides; Swine; Vasoconstrictor Agents

2006
SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1.
    Molecular and cellular biology, 2009, Volume: 29, Issue:15

    Topics: Acetylation; Angiotensin II; Animals; Animals, Newborn; Blotting, Western; Cell Survival; Cells, Cultured; Chlorocebus aethiops; COS Cells; HeLa Cells; Humans; Mice; Mice, Knockout; Myocardium; Myocytes, Cardiac; NAD; Phenylephrine; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerases; Protein Binding; Rats; RNA Interference; Sirtuin 1; Sirtuins; Stress, Mechanical

2009
Resveratrol supplementation gender independently improves endothelial reactivity and suppresses superoxide production in healthy rats.
    Cardiovascular drugs and therapy, 2009, Volume: 23, Issue:6

    Topics: Acetylcholine; Angiotensin II; Animals; Antioxidants; Endothelium, Vascular; Female; Male; NAD; NADP; Nitric Oxide; Phenylephrine; Rats; Resveratrol; Sex Factors; Stilbenes; Superoxides; Vasoconstriction; Vasoconstrictor Agents; Vasodilation; Wine

2009
Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity.
    British journal of pharmacology, 2013, Volume: 168, Issue:1

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Cardiomegaly; Cells, Cultured; Constriction, Pathologic; Male; Myocytes, Cardiac; NAD; NF-kappa B; Rats; Rats, Sprague-Dawley; RNA Interference; RNA, Messenger; Sirtuins; Transcription, Genetic; Ultrasonography; Up-Regulation

2013
Nmnat2 protects cardiomyocytes from hypertrophy via activation of SIRT6.
    FEBS letters, 2012, Mar-23, Volume: 586, Issue:6

    Topics: Amide Synthases; Angiotensin II; Animals; Cardiomegaly; Gene Knockdown Techniques; Isoenzymes; Male; Myocytes, Cardiac; NAD; Nicotinamide-Nucleotide Adenylyltransferase; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Sirtuins; Tissue Distribution

2012
Salvianolic acid B protects cardiomyocytes from angiotensin II-induced hypertrophy via inhibition of PARP-1.
    Biochemical and biophysical research communications, 2014, Feb-14, Volume: 444, Issue:3

    Topics: Angiotensin II; Animals; Benzofurans; Cardiomegaly; Cells, Cultured; Myocytes, Cardiac; NAD; Poly (ADP-Ribose) Polymerase-1; Poly(ADP-ribose) Polymerase Inhibitors; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species; Real-Time Polymerase Chain Reaction

2014
AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy.
    Molecular and cellular endocrinology, 2014, Jul-05, Volume: 392, Issue:1-2

    Topics: Angiotensin II; Animals; Cardiomegaly; Cardiotonic Agents; Cytoprotection; Drug Evaluation, Preclinical; Enzyme Activation; Enzyme Inhibitors; Humans; Inhibitory Concentration 50; Membrane Glycoproteins; Molecular Docking Simulation; Myocytes, Cardiac; NAD; NADPH Oxidase 2; NADPH Oxidase 4; NADPH Oxidases; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Rats, Sprague-Dawley; Reactive Oxygen Species; Recombinant Proteins; Sirtuins; Thioglycolates; Up-Regulation; Xanthines

2014
α7 Nicotinic Acetylcholine Receptor Relieves Angiotensin II-Induced Senescence in Vascular Smooth Muscle Cells by Raising Nicotinamide Adenine Dinucleotide-Dependent SIRT1 Activity.
    Arteriosclerosis, thrombosis, and vascular biology, 2016, Volume: 36, Issue:8

    Topics: alpha7 Nicotinic Acetylcholine Receptor; Angiotensin II; Animals; Cell Proliferation; Cells, Cultured; Cellular Senescence; Disease Models, Animal; Genotype; Histone Deacetylase Inhibitors; Humans; Hypertension; Mice, Knockout; Muscle, Smooth, Vascular; NAD; Nicotinic Agonists; Oxidative Stress; Phenotype; Rats, Sprague-Dawley; RNA Interference; Signal Transduction; Sirtuin 1; Time Factors; Transfection; Up-Regulation

2016
Niacin protects against abdominal aortic aneurysm formation via GPR109A independent mechanisms: role of NAD+/nicotinamide.
    Cardiovascular research, 2020, 12-01, Volume: 116, Issue:14

    Topics: Angiotensin II; Animals; Aorta, Abdominal; Aortic Aneurysm, Abdominal; Calcium Chloride; Cells, Cultured; Dilatation, Pathologic; Disease Models, Animal; Male; Mice, Inbred C57BL; Mice, Knockout; NAD; Niacin; Niacinamide; Receptors, G-Protein-Coupled; Receptors, LDL; Signal Transduction; Sirtuin 1

2020
Angiotensin II induces podocyte metabolic reprogramming from glycolysis to glycerol-3-phosphate biosynthesis.
    Cellular signalling, 2022, Volume: 99

    Topics: Angiotensin II; Dihydroxyacetone Phosphate; Glycerides; Glycerol; Glycerolphosphate Dehydrogenase; Glycerophospholipids; Glycolysis; Lipids; NAD; Phosphates; Podocytes

2022
Nicotinamide Mononucleotide Alleviates Angiotensin II-Induced Human Aortic Smooth Muscle Cell Senescence in a Microphysiological Model.
    Journal of cardiovascular pharmacology, 2023, 04-01, Volume: 81, Issue:4

    Topics: Angiotensin II; Animals; Aortic Aneurysm; Humans; Myocytes, Smooth Muscle; NAD; Nicotinamide Mononucleotide; Nicotinamide Phosphoribosyltransferase

2023
Glycolysis Promotes Angiotensin II-Induced Aortic Remodeling Through Regulating Endothelial-to-Mesenchymal Transition via the Corepressor C-Terminal Binding Protein 1.
    Hypertension (Dallas, Tex. : 1979), 2023, Volume: 80, Issue:12

    Topics: Angiotensin II; Animals; Aorta; Endothelial Cells; Glycolysis; Humans; Mice; NAD; Transcription Factors; Transforming Growth Factor beta; Ubiquitin-Protein Ligases

2023